Castle Knight Management LP Roivant Sciences Ltd. Transaction History
Castle Knight Management LP
- $2.29 Billion
- Q3 2024
A detailed history of Castle Knight Management LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Castle Knight Management LP holds 198,200 shares of ROIV stock, worth $2.22 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
198,200
Previous 289,900
31.63%
Holding current value
$2.22 Million
Previous $3.06 Million
25.36%
% of portfolio
0.1%
Previous 0.16%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
315Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$739 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$738 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$606 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$467 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$397 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.9B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...